198 related articles for article (PubMed ID: 33408053)
1. Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature.
Campi R; Stewart GD; Staehler M; Dabestani S; Kuczyk MA; Shuch BM; Finelli A; Bex A; Ljungberg B; Capitanio U
Eur Urol Oncol; 2021 Feb; 4(1):22-41. PubMed ID: 33408053
[TBL] [Abstract][Full Text] [Related]
2. Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.
Diana P; Klatte T; Amparore D; Bertolo R; Carbonara U; Erdem S; Ingels A; Kara O; Marandino L; Marchioni M; Muselaers S; Pavan N; Pecoraro A; Pecoraro A; Roussel E; Campi R;
World J Urol; 2023 Apr; 41(4):929-940. PubMed ID: 35362747
[TBL] [Abstract][Full Text] [Related]
3. Clinical Application of Digital and Computational Pathology in Renal Cell Carcinoma: A Systematic Review.
Khene ZE; Kammerer-Jacquet SF; Bigot P; Rabilloud N; Albiges L; Margulis V; De Crevoisier R; Acosta O; Rioux-Leclercq N; Lotan Y; Rouprêt M; Bensalah K
Eur Urol Oncol; 2024 Jun; 7(3):401-411. PubMed ID: 37925349
[TBL] [Abstract][Full Text] [Related]
4. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
[TBL] [Abstract][Full Text] [Related]
5. Estimating Postoperative Renal Function After Surgery for Nonmetastatic Renal Masses: A Systematic Review of Available Prediction Models.
Pecoraro A; Campi R; Bertolo R; Mir MC; Marchioni M; Serni S; Joniau S; Van Poppel H; Albersen M; Roussel E
Eur Urol Oncol; 2023 Apr; 6(2):137-147. PubMed ID: 36631353
[TBL] [Abstract][Full Text] [Related]
6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
7. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Ljungberg B; Albiges L; Abu-Ghanem Y; Bensalah K; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Tahbaz R; Volpe A; Bex A
Eur Urol; 2019 May; 75(5):799-810. PubMed ID: 30803729
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic utility of diffusion weighted MRI imaging and ADC ratio to distinguish benign from malignant renal masses: sorting the kittens from the tigers.
de Silva S; Lockhart KR; Aslan P; Nash P; Hutton A; Malouf D; Lee D; Cozzi P; MacLean F; Thompson J
BMC Urol; 2021 Apr; 21(1):67. PubMed ID: 33888122
[TBL] [Abstract][Full Text] [Related]
10. Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma: A Critical Analysis of the Current Literature.
Posada Calderon L; Eismann L; Reese SW; Reznik E; Hakimi AA
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672304
[TBL] [Abstract][Full Text] [Related]
11. Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review.
Roussel E; Capitanio U; Kutikov A; Oosterwijk E; Pedrosa I; Rowe SP; Gorin MA
Eur Urol; 2022 May; 81(5):476-488. PubMed ID: 35216855
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review.
Lommen K; Vaes N; Aarts MJ; van Roermund JG; Schouten LJ; Oosterwijk E; Melotte V; Tjan-Heijnen VC; van Engeland M; Smits KM
Eur Urol Oncol; 2021 Apr; 4(2):215-226. PubMed ID: 31402218
[TBL] [Abstract][Full Text] [Related]
13. EAU guidelines on renal cell carcinoma: 2014 update.
Ljungberg B; Bensalah K; Canfield S; Dabestani S; Hofmann F; Hora M; Kuczyk MA; Lam T; Marconi L; Merseburger AS; Mulders P; Powles T; Staehler M; Volpe A; Bex A
Eur Urol; 2015 May; 67(5):913-24. PubMed ID: 25616710
[TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
15. Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: a systematic review.
Campi R; Berni A; Amparore D; Bertolo R; Capitanio U; Carbonara U; Erdem S; Ingels A; Kara O; Klatte T; Kriegmair M; Marchioni M; Minervini A; Mir MC; Papalia R; Pavan N; Pecoraro A; Gomez Rivas J; Rivasi G; Roussel E; Ungar A; Serni S; Esperto F;
Minerva Urol Nephrol; 2022 Apr; 74(2):146-160. PubMed ID: 34714036
[TBL] [Abstract][Full Text] [Related]
16. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
17. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
18. The Role of Radiolabeled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for the Evaluation of Renal Cancer.
Evangelista L; Basso U; Maruzzo M; Novara G
Eur Urol Focus; 2020 Jan; 6(1):146-150. PubMed ID: 30120074
[TBL] [Abstract][Full Text] [Related]
19. Rationale for percutaneous biopsy and histologic characterisation of renal tumours.
Volpe A; Finelli A; Gill IS; Jewett MA; Martignoni G; Polascik TJ; Remzi M; Uzzo RG
Eur Urol; 2012 Sep; 62(3):491-504. PubMed ID: 22633318
[TBL] [Abstract][Full Text] [Related]
20. CT-based radiomics for differentiating renal tumours: a systematic review.
Bhandari A; Ibrahim M; Sharma C; Liong R; Gustafson S; Prior M
Abdom Radiol (NY); 2021 May; 46(5):2052-2063. PubMed ID: 33136182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
